Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Akron, Ohio 44703


Purpose:

Retrospective chart review of patients who received N-acetylcysteine for APAP toxicity to assess length of oral vs IV treatment and overall healthcare costs.


Criteria:

Inclusion Criteria: - Admitted to CHMCA between June 1, 2004 to May 31, 2008 with a qualifying ICD-9 diagnosis code for the following APAP overdose situations; poisoning, accidental, suicide attempt, therapeutic use, assault, and undetermined (965.4, E850.4, E950.0, E935.4, E962.0, E980.0) - Serum APAP concentrations ≥ 150 g/mL at 4 hours or a serum concentration above the possible hepatotoxic line on the Rumack-Matthew's nomogram if obtained > 4 hours post ingestion - Between the ages of 0-21 years Exclusion Criteria: - Serum APAP concentrations are not actually documented - Patient did not receive oral or IV NAC treatment - Patient has a preexisting liver disease such as cirrhosis or hepatitis C - Patient > 21 years of age


NCT ID:

NCT00725179


Primary Contact:

Principal Investigator
Martha Blackford, PharmD
CHMCA


Backup Contact:

N/A


Location Contact:

Akron, Ohio 44703
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.